Novartis
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
8/10
|
13.91 | 114.26 | -87.82% | 24.92 | -44.18% |
| P/S |
|
4.43 | 4.1 | 7.91% |
|
|
| P/BV |
|
4.42 | 9.02 | -51.03% |
|
|
| P/FCF |
|
17.98 | 44.54 | -59.63% |
|
|
| Ev/Ebitda |
|
11.89 | 17.72 | -32.92% |
|
|
| Ev/S |
|
4.71 | 4.4 | 6.83% |
|
|
| Ev/FCF |
|
18.76 | 54.7 | -65.71% |
|
|
| E/P |
|
0.0706 | 0.2136 | -66.95% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
39.58 | 21.49 | 84.21% | 32.89 | +20.34% |
| ROE |
|
31.82 | -82.41 | -138.62% |
|
|
| ROA |
|
14.86 | 6.75 | 120.09% |
|
|
| ROIC |
|
27.51 | 15.68 | 75.49% |
|
|
| ROS |
|
31.83 | 10.29 | 209.38% |
|
|
| ROCE |
|
21.8 | 55.43 | -60.67% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
8/10
|
1.34 | 0.9571 | 40.02% | 1.39 | -3.71% |
| Nеt Debt/Ebitda |
|
0.7014 | 2.1 | -66.53% |
|
|
| Debt/Ratio |
|
0.2476 | 0.2655 | -6.72% |
|
|
| Debt/Equity |
|
2.03 | 4.83 | -58.04% |
|
|
| Debt/Net Income |
|
1.67 | 35.64 | -95.32% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
9.18/10
|
3.67 | 1.31 | 180.73% | 3.38 | +8.65% |
| Number of years of dividend growth |
|
0 | 6.35 | -100% | ||
| DSI |
|
1 | 0.7501 | 33.31% |
|
|
| Average dividend growth |
|
12.05 | -0.7622 | -1680.9% |
|
|
| Average percentage for 5 years |
|
3.38 | 1.28 | 163.14% |
|
|
| Average percentage for payments |
|
56.19 | 77.77 | -27.74% |
|
|
| Difference from average difference in sector |
|
2.36 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-4.14 | 214.83 | -101.93% | ||
| Growth impulse Ebitda in 5 years |
|
17.1 | 253.48 | -93.25% | ||
| Growth impulse Net Income in 5 years |
|
26.58 | 270.34 | -90.17% | ||
| Growth impulse FCF in 5 years |
|
2.96 | 183.09 | -98.38% | ||
| Growth impulse EPS in 5 years |
|
40.29 | 149.95 | -73.13% |
IP Score
6.74/10
